IL50522A0 - Novel n-aryl-n-(4-piperidinyl)-arylacetamides their preparation and pharmaceutical compositions containing them - Google Patents

Novel n-aryl-n-(4-piperidinyl)-arylacetamides their preparation and pharmaceutical compositions containing them

Info

Publication number
IL50522A0
IL50522A0 IL50522A IL5052276A IL50522A0 IL 50522 A0 IL50522 A0 IL 50522A0 IL 50522 A IL50522 A IL 50522A IL 5052276 A IL5052276 A IL 5052276A IL 50522 A0 IL50522 A0 IL 50522A0
Authority
IL
Israel
Prior art keywords
arylacetamides
piperidinyl
aryl
novel
preparation
Prior art date
Application number
IL50522A
Other versions
IL50522A (en
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL50522A0 publication Critical patent/IL50522A0/en
Publication of IL50522A publication Critical patent/IL50522A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4
IL50522A 1975-09-23 1976-09-21 N-aryl-n(4-piperidinyl)-aryl-acetamides, their preparation and pharmaceutical compositions containing them IL50522A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61513175A 1975-09-23 1975-09-23
US71375676A 1976-08-12 1976-08-12

Publications (2)

Publication Number Publication Date
IL50522A0 true IL50522A0 (en) 1976-11-30
IL50522A IL50522A (en) 1979-09-30

Family

ID=27087421

Family Applications (1)

Application Number Title Priority Date Filing Date
IL50522A IL50522A (en) 1975-09-23 1976-09-21 N-aryl-n(4-piperidinyl)-aryl-acetamides, their preparation and pharmaceutical compositions containing them

Country Status (29)

Country Link
JP (1) JPS6016417B2 (en)
AT (1) AT363935B (en)
AU (1) AU510029B2 (en)
BG (1) BG27543A3 (en)
CA (1) CA1068271A (en)
CH (1) CH628623A5 (en)
CS (1) CS222663B2 (en)
DE (1) DE2642856A1 (en)
DK (1) DK150478C (en)
ES (1) ES451768A1 (en)
FI (1) FI61482C (en)
FR (1) FR2325377A1 (en)
GB (1) GB1539473A (en)
GR (1) GR58469B (en)
HU (1) HU172964B (en)
IE (1) IE43802B1 (en)
IL (1) IL50522A (en)
IT (1) IT1073893B (en)
LU (1) LU75837A1 (en)
NL (1) NL187267C (en)
NO (1) NO147672C (en)
NZ (1) NZ181972A (en)
PH (1) PH12497A (en)
PL (2) PL117323B1 (en)
PT (1) PT65631B (en)
RO (1) RO70079A (en)
SE (1) SE427839B (en)
SU (1) SU747424A3 (en)
YU (1) YU39973B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA765684B (en) * 1975-09-23 1978-04-26 Janssen Pharmaceutica Nv Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
JPS62260786A (en) * 1986-05-08 1987-11-13 株式会社ヘキトク Line system for manufacturing smoked roof tile
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Fast Dissociting Dopamine 2 Receptor Antagonists
JO2642B1 (en) 2006-12-08 2012-06-17 جانسين فارماسوتيكا ان. في Fast Dissociating Dopamine 2 Receptor Antagonists
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Fast -Dissociating Dopamine 2 Receptor Antagonists
ES2400710T3 (en) 2007-04-23 2013-04-11 Janssen Pharmaceutica, N.V. Tia (dia) zoles as fast dissociation dopamine 2 receptor antagonists
JP2010525013A (en) * 2007-04-23 2010-07-22 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
US8906921B2 (en) 2007-04-23 2014-12-09 Janssen Pharmaceutica Nv 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists
WO2010000456A1 (en) 2008-07-03 2010-01-07 Janssen Pharmaceutica Nv Substituted 6- (1-piperazinyl) -pyridazines as 5-ht6 receptor antagonists
EA019048B1 (en) 2008-07-31 2013-12-30 Янссен Фармацевтика Нв Piperazin-1-yl-trifluoromethyl-substituted pyridines as fast dissociating dopamine 2 receptor antagonists

Also Published As

Publication number Publication date
BG27543A3 (en) 1979-11-12
AU1787876A (en) 1978-03-23
PH12497A (en) 1979-04-05
ES451768A1 (en) 1978-05-01
NO147672C (en) 1983-05-25
GB1539473A (en) 1979-01-31
IE43802B1 (en) 1981-06-03
RO70079A (en) 1982-10-26
FR2325377A1 (en) 1977-04-22
CA1068271A (en) 1979-12-18
PL192578A1 (en) 1979-02-26
DE2642856C2 (en) 1990-06-21
DK150478C (en) 1987-10-05
PT65631A (en) 1976-10-01
GR58469B (en) 1977-10-14
DK427876A (en) 1977-03-24
NZ181972A (en) 1978-07-28
JPS5239683A (en) 1977-03-28
DE2642856A1 (en) 1977-03-24
FI61482B (en) 1982-04-30
NO763054L (en) 1977-03-24
NO147672B (en) 1983-02-14
AT363935B (en) 1981-09-10
NL187267B (en) 1991-03-01
IL50522A (en) 1979-09-30
YU39973B (en) 1985-06-30
ATA702976A (en) 1981-02-15
NL187267C (en) 1991-08-01
LU75837A1 (en) 1977-05-04
SE7610501L (en) 1977-03-24
IE43802L (en) 1977-03-23
SU747424A3 (en) 1980-07-23
PL117323B1 (en) 1981-07-31
SE427839B (en) 1983-05-09
HU172964B (en) 1979-01-28
PT65631B (en) 1978-07-05
CS222663B2 (en) 1983-07-29
CH628623A5 (en) 1982-03-15
YU233676A (en) 1983-01-21
IT1073893B (en) 1985-04-17
NL7610513A (en) 1977-03-25
FR2325377B1 (en) 1980-04-18
AU510029B2 (en) 1980-06-05
JPS6016417B2 (en) 1985-04-25
FI61482C (en) 1982-08-10
DK150478B (en) 1987-03-09
FI762698A (en) 1977-03-24

Similar Documents

Publication Publication Date Title
IL50836A0 (en) Novel cyclopolypeptides their production and pharmaceutical compositions containing them
IL49204A0 (en) N-(4-piperidinyl)-n-phenylamides and-carbamates,their preparation and pharmaceutical compositions containing them
IL50632A0 (en) Pyridinyl-2(1h)-pyridinones their preparation and pharmaceutical compositions containing them
IL49238A (en) O-aminoethyl trifluoromethyl-phenyl-ketoximes, their preparation and pharmaceutical compositions containing them
IL50815A0 (en) New aminobenzoamides their preparation and pharmaceutical compositions containing them
IL50176A0 (en) Novel tetrahydroisoquinoline derivatives,their preparation and pharmaceutical compositions containing them
IL51087A0 (en) New polyhalogeno-steroids their manufacture and pharmaceutical compositions containing them
IL50631A (en) 1-benzazolylalkyl-4-substituted-piperidines their preparation and pharmaceutical compositions containing them
IL49447A0 (en) Novel lysergic acid amides,their preparation and pharmaceutical compositions containing them
IL49424A0 (en) 1,1,1-triaryl-alkylamines,their preparation and pharmaceutical compositions containing them
IL49788A0 (en) 11-desoxy-16-aryloxy-omega-pentanorprostaglandins,their preparation and pharmaceutical compositions containing them
GB1547232A (en) Pharmaceutical compositions
IL50522A0 (en) Novel n-aryl-n-(4-piperidinyl)-arylacetamides their preparation and pharmaceutical compositions containing them
NZ181503A (en) Substituted diphenyls-ulphides and pharmaceutical compositions
NZ182591A (en) 14-substituted-daunorubicins and pharmaceutical compositions
IL50542A0 (en) Novel substituted pyridinecarboxamides their manufacture and pharmaceutical compositions containing them
IL48453A0 (en) Novel quinuclidine derivatives and pharmaceutical compositions containing them
NZ182581A (en) -amino-ketones and pharmaceutical compositions
NZ181864A (en) Noroxymorphones and pharmaceutical compositions
IL49132A (en) 16,1l-disubstituted androst-4-en-3-ones,their preparation and pharmaceutical compositions containing them
IL49099A (en) Xanthene-9-carboxylates, their preparation and pharmaceutical compositions containing them
GR60551B (en) Pharmaceutical compositions containing heterocolloidal debrycin and process for the preparation thereof
IL50945A0 (en) Novel cephalosporins their preparation and pharmaceutical compositions containing them
IL50554A0 (en) Novel 2,9-dioxatricyclodecanes their preparation and pharmaceutical compositions containing them
IL49239A (en) O-aminoethyl methylthiophenyl-ketoximes, their preparation and pharmaceutical compositions containing them